Get the Stockscreener App
102.34
0.72%
-0.74
After Hours:
102.21
-0.13
-0.13%
Boston Scientific Corp stock is traded at $102.34, with a volume of 6.51M.
It is down -0.72% in the last 24 hours and up +0.77% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
See More
Previous Close:
$103.08
Open:
$103.12
24h Volume:
6.51M
Relative Volume:
1.01
Market Cap:
$150.81B
Revenue:
$16.75B
Net Income/Loss:
$1.85B
P/E Ratio:
81.87
EPS:
1.25
Net Cash Flow:
$2.37B
1W Performance:
+1.60%
1M Performance:
+0.77%
6M Performance:
+23.18%
1Y Performance:
+50.63%
1-Day Range:
$101.02
$103.48
1-Week Range:
$99.30
$104.35
52-Week Range:
$66.80
$107.17
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
102.34 | 150.81B | 16.75B | 1.85B | 2.37B | 1.25 |
|
ABT
Abbott Laboratories
|
126.61 | 218.04B | 41.95B | 13.40B | 6.35B | 7.65 |
|
SYK
Stryker Corp
|
367.77 | 142.81B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.23 | 115.57B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.09 | 41.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
The Zacks Analyst Blog Boston Scientific, Abbott and Medtronic - Yahoo Finance
Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Market Makes A Big Shift: DoorDash, Heico, Boston Scientific In Focus - Investor's Business Daily
Boston Scientific SVP Vance Brown sells shares worth $486,702 - Investing.com India
Returns Are Gaining Momentum At Boston Scientific (NYSE:BSX) - Yahoo Finance
Boston Scientific CEO gets 14% boost in compensation - The Business Journals
November 21st Options Now Available For Boston Scientific (BSX) - Nasdaq
RBC Capital maintains Outperform on Boston Scientific shares, $116 target - Investing.com
Investors more bullish on Boston Scientific (NYSE:BSX) this week as stock grows 5.6%, despite earnings trending downwards over past five years - Yahoo Finance
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Boston Scientific Corporation Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – BSX - Business Wire
Form DEF 14A BOSTON SCIENTIFIC CORP For: Mar 19 - StreetInsider.com
Medtronic, Abbott Block Boston Scientific Heart Valve IP - Law360
Is Boston Scientific Corporation (BSX) the Top Stock to Buy According to Marshall Wace LLP? - Insider Monkey
Boston Scientific (BSX) Gains As Market Dips: What You Should Know - Yahoo Finance
Boston Scientific (BSX) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Neurotech Devices Market Is Booming Worldwide 2025-2032 | - openPR
Here's Why We Think Boston Scientific (NYSE:BSX) Is Well Worth Watching - Yahoo Finance
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now? - Yahoo Finance
Boston Scientific’s SWOT analysis: medtech giant’s stock poised for growth By Investing.com - Investing.com South Africa
Boston Scientific’s SWOT analysis: medtech giant’s stock poised for growth - Investing.com
Neurosurgery Market Size to Reach USD 6.8 Billion by 2034, Growing at 4.5% CAGR with Technological Advancements and Rising Focus on Personalized Medicine – Analysis by TMR - GlobeNewswire Inc.
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Boston Scientific (NYSE:BSX) Sees 4% Price Rise Following Strong Earnings Report - Yahoo Finance
Boston Scientific Gains 42.2% in a Year: What's Driving the Stock? - Yahoo Finance
Boston Scientific price target raised to $110 from $100 at Bernstein - MSN
Estimating The Fair Value Of Boston Scientific Corporation (NYSE:BSX) - Yahoo Finance
4C raises $175M for mitral valve technology - BioWorld Online
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
How Boston Scientific (sort of) became ‘Minnesota Scientific’ - Star Tribune
Boston Scientific at TD Cowen Conference: Strategic Growth Insights - Investing.com
Boston Scientific leads $175M investment in 4C Medical - MedTech Dive
Boston Scientific (BSX) Gains But Lags Market: What You Should Know - Yahoo Finance
Ajax, Boston Sci partner to develop new heart failure treatment - BioWorld Online
Boston Scientific Stock: Is BSX Outperforming the Healthcare Sector? - Nasdaq
Insider Sell: Jeffrey Mirviss Sells 13,022 Shares of Boston Scie - GuruFocus.com
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views? - Yahoo Finance
Boston Scientific Stock: Is BSX Outperforming The Healthcare Sector? - Barchart
Five things you need to know, and going for a chilly swim - The Business Journals
Goldman Sachs Adjusts Price Target on Boston Scientific to $119 From $118, Keeps Buy Rating - Marketscreener.com
Boston Scientific buys Tivus system developer SoniVie in $540m deal - Medical Device Network
Boston Scientific Buying $600M Ultrasound System Developer - Law360
Boston Scientific to acquire Sonivie for up to $600M - BioWorld Online
Beyond The Numbers: 17 Analysts Discuss Boston Scientific Stock - Benzinga
Boston Scientific makes second acquisition for $360M upfront - The Business Journals
Boston Scientific to Purchase SoniVie Ltd. - MPO-mag
Boston Scientific to acquire renal denervation company SoniVie - Mass Device
Boston Scientific Announces Agreement To Acquire Sonivie Ltd -March 03, 2025 at 08:55 am EST - Marketscreener.com
Boston Scientific to acquire remaining 90% stake of SoniVie for $360M - TipRanks
Boston Scientific To Buy SoniVie For Upfront Payment Of Approx. $360 Mln - Nasdaq
Boston Scientific announces agreement to acquire SoniVie Ltd. - Quantisnow
The Zacks Analyst Blog The Goldman Sachs, The Progressive, Boston Scientific and Cooper-Standard - Zacks Investment Research
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.37%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):